{
  "url": "https://www.law.cornell.edu/regulations/new-york/14-NYCRR-527.8",
  "title": "N.Y. Comp. Codes R. & Regs. Tit. 14 ยง 527.8 - Care and treatment; right to object",
  "content": "N.Y. Comp. Codes R. & Regs. Tit. 14 ยง 527.8 - Care and treatment; right to object\n\nState Regulations\n(a) Definitions. (1)\n\nBest interests means, with respect to any\nproposed treatment, that it will promote the well-being of a patient, taking\ninto account the benefits, including improvement in the quality of the\npatient's life, risks and alternatives to the treatment. (2)\n\nCapacity means the patient's ability to\nfactually and rationally understand and appreciate the nature and consequences\nof proposed treatment, including the benefits, risks and alternatives to the\nproposed treatment, and to thereby make a reasoned decision about undergoing\nthe proposed treatment. (3)\n\nClinical director means the individual in charge of clinical services at the\nhospital or a secure treatment facility operated by the Office of Mental Health\nas defined in section\n10.03\nof\nthe Mental Hygiene Law, where the patient is receiving care and treatment, or a\nphysician designated by that individual to carry out the responsibilities of\nthe clinical director described in this section. (4)\n\nDangerous means that a patient engages in\nconduct or is imminently likely to engage in conduct posing a risk of physical\nharm to himself or others. (5)\n\nMinor means a patient who is under the age of 18 and is not married or the\nparent of a child, and is not on voluntary status on his or her own\napplication. A patient under the age of 18 who does not meet the above criteria\nshall, for the purposes of this section, be considered an adult. (6)\n\nPatients on involuntary status for the\npurposes of this section includes patients retained on an involuntary basis\npursuant to article 9 of the Mental Hygiene Law, patients retained pursuant to\nthe Criminal Procedure Law, Family Court Act or Correction Law, patients on\nvoluntary status for whom application to a court for involuntary retention has\nbeen made, minors, other than those admitted on their own application, for whom\nconsent of a parent or guardian cannot be obtained, and persons confined or\ncommitted to a secure treatment facility operated by the Office of Mental\n\nHealth as defined in section\n10.03\nof\nthe Mental Hygiene Law. (7)\n\nTreatment for purposes of this section means diagnostic procedures or\ntherapeutic actions on behalf of a patient, including administration of\npsychotropic medications, extraction of bodily fluids for analysis (excluding\nroutine blood work), dental care performed with a local anesthetic, biopsies, CAT/PET scans, or similar medical or dental procedures. For purposes of this\nsection, such term also includes electroconvulsive therapy. Such term does not\ninclude, and this section does not apply to, routine medical procedures such as\nphysical examinations, routine blood work, X-rays and nonpsychotropic\nmedication. It also does not include, and does not apply to, procedures for\nwhich informed consent is required under section\n27.9\nof this Title, except\nelectroconvulsive therapy, or under other provisions of law. (8)\n\nInmate patient means a person committed\nto the custody of the Department of Corrections and Community Supervision who\nis an outpatient of Central New York Psychiatric Center at the regional medical\nunits operated by the Department of Corrections and Community Supervision at\nwhich the Office of Mental Health provides outpatient psychiatric treatment, and at correctional facilities operated by the Department of Corrections and\n\nCommunity Supervision at which the Office of Mental Health operates a\nresidential crisis treatment program. (b) Except as provided in this subdivision, facilities shall ensure that each patient is afforded an explanation of any\nproposed medical procedure or course of treatment. Such explanation shall\ninclude a discussion of the expected benefits, reasonably foreseeable risks, and any reasonable alternatives to the proposed procedure or treatment. (1)\nA facility may withhold all or part of\nthe explanation from any patient if the risk of treatment is minimal and too\ncommonly known to warrant disclosure, or if in the judgment of the treating\nphysician, providing such explanation would be likely to have an identifiable\nand substantial adverse effect upon the patient's condition. In any such case, the facility shall ensure that this determination is fully documented and that\nthe patient is reevaluated monthly and provided appropriate explanation\nwhenever the treating physician determines that an explanation would no longer\nbe likely to have an identifiable and substantial adverse effect upon the\npatient's condition. (2)\nA facility\nmay withhold all or part of the explanation from any patient under the age 18, other than a patient admitted on his own application, who is not married or the\nparent of a child. In determining whether to withhold all or any part of the\nexplanation, the facility shall consider the patient's age and\nmaturity. (c) Patients\nwho object to any proposed medical treatment or procedure as defined above may\nnot be treated over their objection except as follows: (1)\n\nEmergency treatment. Facilities may give\ntreatment, except electroconvulsive therapy, to any inpatient, regardless of\nadmission status or objection, where the patient is presently dangerous and the\nproposed treatment is the most appropriate reasonably available means of\nreducing that dangerousness. Such treatment may continue only as long as\nnecessary to prevent dangerous behavior. (2)\n\nMinors. (i) Except as provided in subparagraph (ii)\nof this paragraph, a patient who is a minor may be provided treatment over his\nor her objection if the patient's parent, legal guardian or other legally\nauthorized representative has consented to the treatment, and the treatment is\nnot one for which the consent of a minor would be legally sufficient. (ii)\n\nIf an individual, who is a minor and is\na patient in a State-operated psychiatric center, objects to psychotropic\nmedication to which his or her parent, legal guardian or other legally\nauthorized representative has consented, such medication shall not be\nadministered pending the completion of the following process, which shall be\nfully documented: (a) Upon the patient's\nobjection to the proposed treatment, an independent review shall be conducted\nby a physician who specializes in psychiatry and is not an employee of the\nfacility. Such independent reviewer, designated by the clinical director, shall\nreview the patient's clinical record, meet with the patient, and provide a\nrecommendation to the clinical director based on an assessment of: (1)\nthe need for the proposed treatment in\nlight of the patient' s current condition, the goals for the treatment, the\npatient's treatment history, any alternatives to the treatment and the\ntherapeutic implications of treating the patient over his or her objection; and\n(2)\nthe patient's reasons for\nobjecting to the proposed treatment, his or her ability to understand the\nfactors described in subclause (1) of this clause, and the treatment staff's\nresponses to the patient's objection. (b) Following the completion of the\nindependent review, the clinical director shall also conduct a review as\ndescribed in clause (a) of this subparagraph. Based on the clinical director's\nreview and the independent reviewer's recommendation, the clinical director\nshall determine that the treatment: (1)\nbe\nadministered over the patient's objection; or\n(2)\nbe administered after the delay of a\nspecified period of time to permit efforts to obtain the patient's agreement; or\n(3)\nnot be administered as not\nin the patient's best interests. (c) The clinical director shall provide the\npatient and his or her parent, legal guardian or other legally authorized\nrepresentative with a full explanation of the clinical director's\ndetermination. If the determination is made to administer non-emergency\ntreatment over the patient's objection, the Mental Hygiene Legal Service shall\nbe notified and the initiation of the treatment shall be delayed at least four\ncalendar days thereafter. If, within the four-day period, the Mental Hygiene\n\nLegal Service files a legal action on behalf of the patient challenging the\nclinical director's determination as \"arbitrary and capricious\", the treatment\nmay be initiated three calendar days thereafter, unless otherwise ordered by\nthe court. (3)\n\nPatients on voluntary or informal status. Except as provided in paragraphs (1) and (2) of this subdivision, patients who\nare on a voluntary or informal status, other than those for whom application to\na court for involuntary retention has been made, may not be given treatment\nover their objection. When any such patient objects to all recommended forms of\ntreatment, the facility director may, after notifying the patient, discharge\nthe patient in accordance with a written service plan or, if appropriate, convert the patient to involuntary status. When a patient is discharged because\nof objection to all recommended forms of treatment, the director shall take\nappropriate steps to notify the patient' s family. (4)\n\nPatients on involuntary status. (i) Except in emergency circumstances as\nprovided in paragraph (1) of this subdivision, or in cases involving minors in\nwhich consent for treatment is obtained in accordance with paragraph (2) of\nthis subdivision, and except for cases involving major medical treatment, which\nare governed by section\n27.9\nof this Title, patients on\ninvoluntary status may not be given a medical procedure or course of treatment\nover their objection without court authorization. (ii)\n\nPrior to requesting court authorization\nto treat an objecting patient on involuntary status, the clinical director of a\nfacility or his or her designee must determine that treatment is in the\npatient's best interests and that the patient lacks capacity to make a reasoned\ndecision concerning treatment. In making such determination, the facility shall\nensure compliance with the procedures described below. In the interest of\nspeedy resolution of conflicts regarding treatment, each of the evaluations of\na patient described below should be completed within 24 hours. (a) Evaluation by treating physician. Upon a\npatient's objection to the proposed treatment, the treating physician shall\nformally evaluate whether the treatment is in the patient's best interests, in\nlight of all relevant circumstances including the risks, benefits and\nalternatives to the patient of the treatment, and the nature of the patient's\nobjection thereto, and whether the patient has the capacity to make a reasoned\ndecision concerning the treatment. If the physician finds that treatment is in\nthe patient's best interests and the patient lacks capacity to make a reasoned\ndecision concerning treatment, he shall personally inform the patient of his\ndetermination. If the patient continues to object to the proposed treatment, the physician shall forward his evaluation and findings to the clinical\ndirector with a request for further review. He shall also notify in writing the\npatient, MHLS, and any other representative of the patient of his determination\nand request, if any, for further review. (b) Review by the clinical director or his\ndesignee. (1)\n\nUpon receipt of the treating\nphysician's request for further review, the clinical director shall appoint a\nphysician to evaluate whether the proposed treatment is in the patient's best\ninterests, and whether the patient has the capacity to make a reasoned decision\nconcerning treatment. The reviewing physician may be any physician of suitable\nexpertise relative to the proposed treatment and may be an employee of the\nfacility, including the clinical director, or independent of the facility. In\nperforming his evaluation, such physician shall review the patient's record and\npersonally examine the patient. If the reviewing physician's determination is\nthat treatment over objection is appropriate, he shall personally inform the\npatient of his determination. (2)\n\nIf there is a substantial discrepancy between the opinions of the treating\nphysician and reviewing physician regarding the patient's capacity or whether\ntreatment is in the patient's best interests, the clinical director may, at his\noption, appoint a third physician to conduct an evaluation pursuant to this\nsubparagraph. (3)\n\nIf, after\ncompletion of the evaluation by the reviewing physician (or physicians), the\npatient continues to object to the proposed treatment, the clinical director\nshall make a determination on behalf of the facility whether the patient has\ncapacity to make a reasoned decision concerning treatment and whether treatment\nis in the patient's best interests. If the clinical director finds that the\npatient has capacity to make a reasoned decision concerning treatment or that\ntreatment would not be in the patient's best interests, he shall uphold the\npatient's objections and so notify the patient, MHLS, and any other patient\nrepresentative. If the clinical director's determination is that the patient\nlacks capacity, and treatment over objection is in the patient's best\ninterests, he may apply for court authorization of treatment, and so notify the\npatient, MHLS, and any other representative of the\npatient. (5)\n\nInmate patients. (i) Except in emergency circumstances as\nprovided in paragraph (1) of this subdivision, an inmate patient may not be\ngiven a psychotropic medication over his or her objection without court\nauthorization. (ii)\n\nPrior to\nrequesting court authorization to administer psychotropic medication to an\nobjecting inmate patient, the clinical director, or his or her designee, of\n\nCentral New York Psychiatric Center, must determine that the administration of\npsychotropic medication is in the inmate patient's best interests and that the\ninmate patient lacks capacity to make a reasoned decision concerning\nadministration of such medication. In making such determination, the clinical\ndirector, or his or her designee, shall ensure compliance with the procedures\ndescribed below. In the interest of prompt resolution of conflicts regarding\nadministration of psychotropic medication over objection, each of the\nevaluations of an inmate patient described below should be completed within 24\nhours. (a) Evaluation by treating physician. Upon an inmate patient's objection to the proposed administration of\npsychotropic medication, the treating physician shall formally evaluate whether\nthe administration of psychotropic medication is in the inmate patient's best\ninterests, in light of all relevant circumstances including the risks, benefits\nand alternatives to the inmate patient of the administration of psychotropic\nmedication, and the nature of the inmate patient's objection thereto, and\nwhether the inmate patient has the capacity to make a reasoned decision\nconcerning the administration of such medication. If the physician finds that\nadministration of psychotropic medication is in the inmate patient's best\ninterests and the inmate patient lacks capacity to make a reasoned decision\nconcerning administration of such medication, he or she shall personally inform\nthe inmate patient of his or her determination. If the inmate patient continues\nto object to the proposed psychotropic medication, the physician shall forward\nhis or her evaluation and findings to the clinical director with a request for\nfurther review. He or she shall also notify in writing the inmate patient, Mental Hygiene Legal Service, and any other representative of the inmate\npatient of his or her determination and request, if any, for further\nreview. (b) Review by the clinical\ndirector or his or her designee. (1)\n\nUpon\nreceipt of the treating physician's request for further review, the clinical\ndirector shall appoint a physician to evaluate whether the proposed\nadministration of psychotropic medication is in the inmate patient's best\ninterests, and whether the inmate patient has the capacity to make a reasoned\ndecision concerning treatment. The reviewing physician may be any physician of\nsuitable expertise relative to the proposed administration of psychotropic\nmedication and may be an employee of the facility, including the clinical\ndirector, or independent of the facility. In performing his or her evaluation, such physician shall review the inmate patient's record and personally examine\nthe inmate patient. If the reviewing physician's determination is\nadministration of psychotropic medication over objection is appropriate, he or\nshe shall personally inform the inmate patient of his determination. (2)\n\nIf there is a substantial discrepancy\nbetween the opinions of the treating physician and reviewing physician\nregarding the inmate patient's capacity or whether administration of\npsychotropic medication is in the inmate patient's best interests, the clinical\ndirector may, at his or her option, appoint a third physician to conduct an\nevaluation pursuant to this subparagraph. (3)\n\nIf, after completion of the evaluation by\nthe reviewing physician (or physicians), the inmate patient continues to object\nto the proposed administration of psychotropic medication, the clinical\ndirector shall make a determination on behalf of the facility whether the\ninmate patient has capacity to make a reasoned decision concerning the\nadministration of psychotropic medication and whether such medication is in the\ninmate patient's best interests. If the clinical director finds that the inmate\npatient has capacity to make a reasoned decision concerning the administration\nof psychotropic medication or that such medication would not be in the inmate\npatient's best interests, he or she shall uphold the inmate patient's\nobjections and so notify the inmate patient, Mental Hygiene Legal Service, and\nany other representative of the inmate patient. If the clinical director's\ndetermination is that the inmate patient lacks capacity, and psychotropic\nmedication over objection is in the inmate patient's best interests, he or she\nmay apply for court authorization of administration of psychotropic medication, and so notify the inmate patient, Mental Hygiene Legal Service, and any other\nrepresentative of the inmate patient. (6)\n\nNothing in this subdivision\nshall prevent a treating physician, treatment team, or others involved in the\npatient's or inmate patient's care from continuing to explain the proposed\ntreatment to the patient as described in subdivision (a) of this section and to\nseek his or her voluntary agreement thereto. Further, the facility shall ensure\nthat any such efforts are made in a clinically appropriate manner. A patient or\ninmate patient may at any time withdraw his or her objection to the proposed\ntreatment, and the treating physician may at any time substitute another\nprofessionally acceptable course of treatment to which the patient or inmate\npatient does not object. Upon the withdrawal of the patient's or inmate\npatient's objection or his or her agreement to a substituted course of\ntreatment, the physician shall immediately notify by telephone Mental Hygiene\n\nLegal Service and the patient's or inmate patient's attorney, if any. Unless\nthe patient or inmate patient, Mental Hygiene Legal Service or the patient's or\ninmate patient's attorney renews the objection, treatment may be commenced 24\nhours after notice has been provided. If the Mental Hygiene Legal Service or\nthe patient's or inmate patient's attorney agrees, treatment may be commenced\nimmediately. Notwithstanding a patient's or inmate patient's withdrawal of his\nor her objection to a proposed treatment, nothing in this paragraph shall\ndiminish or supersede the need for obtaining informed consent for the proposed\ntreatment when so required under section\n27.9\nof this Title or under other\nprovisions of law. (d) Notwithstanding the provisions of this Section, no facility shall provide\nservices to minor patients that are intended to change such minor's sexual\norientation or gender identity, including efforts to change behaviors, gender\nexpressions, or to eliminate or reduce sexual or romantic attractions or\nfeelings towards individuals of the same sex, provided, however, that this does\nnot include counseling or therapy for a minor who is seeking to undergo a\ngender transition or who is in the process of undergoing a gender transition, that provides acceptance, support, and understanding of minors or the\nfacilitation of minors' coping, social support, and identity exploration and\ndevelopment, including sexual orientation-neutral interventions to prevent or\naddress unlawful conduct or unsafe sexual practices, provided that the\ncounseling or therapy does not seek to change sexual orientation or gender\nidentity. Notes\nN.Y. Comp. Codes\nR. & Regs. Tit. 14\nยง\n527.8\n\nAmended\n\nNew\n\nYork State Register April 27, 2016/Volume XXXVIII, Issue 17, eff. 4/27/2016\n\nState regulations are updated quarterly; we currently have two versions available. Below is a\ncomparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare. No prior version found.",
  "url_type": "regulation",
  "source_index": 26903
}